1. What makes a hydrogen inhaler 'clinical grade' — and what does not.
'Clinical' is used liberally in the hydrogen inhaler market. It appears in product names, category descriptions and marketing copy — often without a definition attached.
For a hydrogen inhaler to genuinely qualify as clinical grade, five criteria should be demonstrably met:
- Pure H₂ output above 2,000 ml/min — the output level used in published research protocols. Not total gas output. Pure hydrogen specifically.
- Multi-user capability — clinical environments run parallel sessions. A single-user machine is not clinical grade regardless of its output.
- Continuous duty cycle — the machine must be rated for back-to-back sessions without thermal throttling or mandatory rest periods.
- Published certification stack — independently issued certificates with verifiable certificate numbers, issuing bodies and expiry dates. Not logos. Documents.
- Published stack life rating — a clinical machine is an investment. The manufacturer should publish how long the electrolysis membrane is rated to last under continuous operation.
A machine that meets all five criteria is clinical grade. A machine that meets two or three — and uses the word 'clinical' in its name — is a marketing decision, not an engineering one.
2. Pure H₂ output vs total output — the most misunderstood specification in the category.
PEM/SPE electrolysis splits water into hydrogen and oxygen in a 2:1 ratio by volume — two parts hydrogen, one part oxygen.
A machine stating '3,000 ml/min' output is likely producing:
- 2,000 ml/min pure H₂
- 1,000 ml/min O₂
The 3,000 ml/min figure is total gas output — not pure hydrogen output. A buyer comparing machines on total output figures is not comparing like for like.
What to look for
The specification should state pure H₂ output separately from total output. If only one figure is published and it is described as 'total flow' or 'gas output' without specifying the hydrogen component — divide by 1.5 to estimate pure H₂.
Why it matters
Published protocols on hydrogen inhalation reference H₂ concentration and delivery rate — not total gas output. A protocol calling for 2,000 ml/min pure H₂ needs a machine rated to deliver that figure specifically.
Published figures on our range
3. Five things to verify before buying any clinical hydrogen inhaler in the USA.
1. Certification documents — not logos
Every certification displayed on a product page should be backed by a document — a certificate with a number, an issuing laboratory name and an expiry date.
CE, RoHS and ISO certifications are issued by accredited third-party bodies. A manufacturer cannot self-certify.
What to ask: 'Can you provide the actual certificate document for each certification listed — including the certificate number and issuing body?'
If the seller cannot provide documents — the certifications are unverified claims.
Our certification documents are published at hydrogenmachines.com.au/certifications. Request the equivalent from any seller you are considering.
2. Pure H₂ output — specifically stated
As covered in Section 2 — confirm the pure H₂ figure separately from total output. If a seller cannot provide this figure in writing, the specification is unverified.
3. Stack life rating — in hours
The electrolysis membrane degrades over time. A clinical machine should carry a published stack life rating — typically 8,000–10,000 hours for a correctly engineered PEM/SPE cell.
No published stack life rating means one of two things: the manufacturer does not know the figure, or the figure is not worth publishing.
Our QY-A3000 and QY-F6000 carry a 10,000-hour rated stack life — confirmed by the manufacturer and published on the product page.
At 2 hours daily: 13.6 years before the cell reaches rated end-of-life.
4. Manufacturing quality management certification
ISO 13485 is the quality management standard used by medical device manufacturers. It covers how the factory is run — process controls, documentation, audit trails — not just the product that leaves it.
A machine built in an ISO 13485 certified facility has been manufactured under a documented quality system that has been independently audited.
Ask: 'Is this machine manufactured in an ISO 13485 certified facility? Can you provide the ISO 13485 certificate?'
Our entire range is manufactured in ISO 13485 certified facilities. Certificate available at /certifications.
ISO 13485 describes the manufacturing facility's quality system — not the medical or therapeutic status of the device itself. Our products are general wellness devices.
5. Pricing transparency — is the price real?
This is covered in detail in Section 4 below — but the short version: confirm whether the current price is the actual price or a manufactured discount from an inflated original price.
A machine that has been 'on sale' at the same price for months or years is not discounted — the sale price is the actual price. Evaluate it as such.
4. On pricing transparency — what 'was/now' pricing actually means.
The US hydrogen inhaler market includes machines listed at significant 'original' prices — $8,000, $9,796, $12,000 — with permanent or semi-permanent 'sale' prices substantially lower.
This is anchor pricing — a well-documented direct response marketing technique where an inflated original price makes the sale price appear to represent exceptional value.
How to evaluate it
Step 1: Search for the product at the 'original' price. Has it ever appeared at that price on any retailer, marketplace or price history tool?
Step 2: Check how long the 'sale' has been running. A sale that has run for six months or longer is not a sale — it is the price.
Step 3: Evaluate the machine at the sale price only. Ignore the original price entirely. Does the sale price represent good value for the published specifications?
Step 4: Compare the sale price against direct-price suppliers who do not use anchor pricing. The comparison may surprise you.
Our pricing
We do not use anchor pricing. The price on our product pages is the price — no original price, no permanent sale, no manufactured urgency. Direct from the manufacturer to you without distributor margin at any stage.
5. The US clinical hydrogen inhaler market — 2026.
The genuine clinical-grade hydrogen inhaler market in the USA in 2026 is small. There are a limited number of machines that meet all five clinical criteria defined in Section 1.
The most prominently marketed US brand in this category is Vital Reaction — their 3000mL Clinical Inhaler is currently the most visible product in the clinical inhaler segment.
Our QY-A3000 and QY-F6000 are available to US buyers at direct price with free delivery to all 50 states and duties included.
The full comparison follows.